Phentermine Over the Counter Alternative 2026 – OTC Appetite Suppressant Search Trend Analysis Positions PhenQ as a Market Leader According to 1200 Doctors 
Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762
Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026King of Prussia, Pennsylvania--(Newsfile Corp. - December...
LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for Its State-of-the-Art Test Demonstration Facility Located at the K-1330 Building on the Historic K-25 Site
LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Reached Critical Regulatory Milestone with Receipt of...
LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for Its State-of-the-Art Test Demonstration Facility Located at the K-1330 Building on the Historic K-25 Site
LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Reached Critical Regulatory Milestone with Receipt of...
Miami Physician Dr. Alonso Martin Addresses Public Safety Risks Following Report of Illegal Botox Injections in Brickell
Dr. Martin discusses how counterfeit neurotoxins and non-medical providers can lead to preventable complications and long-term harm. MIAMI, FL /...
Miami Physician Dr. Alonso Martin Addresses Public Safety Risks Following Report of Illegal Botox Injections in Brickell
Dr. Martin discusses how counterfeit neurotoxins and non-medical providers can lead to preventable complications and long-term harm. MIAMI, FL /...
Amazing Community Support Signals Huge Success for Today’s “Toys for Joy” Giveaway Organized by Rapper Mistah F.A.B. and Oakland’s Church of Ambrosia
OAKLAND, CA / ACCESS Newswire / December 23, 2025 / The Church of Ambrosia and Oakland Rapper Mistah F.A.B. expect...
Amazing Community Support Signals Huge Success for Today’s “Toys for Joy” Giveaway Organized by Rapper Mistah F.A.B. and Oakland’s Church of Ambrosia
OAKLAND, CA / ACCESS Newswire / December 23, 2025 / The Church of Ambrosia and Oakland Rapper Mistah F.A.B. expect...
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July...
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total...
MannKind Shares FUROSCIX® Business Updates
FDA approves FUROSCIX® for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow™ Autoinjector WESTLAKE...
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a...
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
ROCHESTER, N.Y., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to...
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
Jupiter, Florida, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical...
CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors
Enters into Cooperation Agreement with Browning WestSAN RAMON, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading...
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
Financing included participation by healthcare-dedicated investors alongside existing shareholdersTORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN)...
Cassava Announces Agreement to Settle Securities Class Action Litigation
AUSTIN, Texas, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused...
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
Milestone advances manufacturing readiness and supports long-term commercialization strategyBURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone...
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy...
Immuneering to Announce 12-Month Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on January 7, 2026
NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping...
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
--Plans to double the Number of Patients in Study-- --Company Expects Initial Findings to be presented in 2026-- BOCA RATON, Fla.,...